Insulet Corporation has underperformed the healthcare sector over the past year. However, analysts remain strongly bullish about its prospects.
/Zimmer%20Biomet%20Holdings%20Inc%20HQ%20photo-by%20jetcityimage%20via%20iStock.jpg)
Zimmer Biomet has lagged the broader S&P 500 Index over the past year, and analysts remain on the sidelines as they weigh the company's steady fundamentals against its modest growth outlook.
WARSAW, Ind. , June 2, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team...
2 Profitable Stocks to Consider Right Now and 1 We Question
WARSAW, Ind. , May 22, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment...
/Zimmer%20Biomet%20Holdings%20Inc%20phone%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
While Zimmer Biomet has lagged behind the SPX over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.
WARSAW, Ind. , May 12, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it now anticipates repurchasing up to $1 billion...